Poland· PL-100090046
Septosan fix
A medicinal product containing thymi herba + salviae folium + menthae piperitae folium, registered in Poland by Zakłady Farmaceutyczne POLPHARMA S.A..
Checked against URPL (Poland) on
Informational only — not a medical device.
The record
At a glance
URPL (Poland)- Active substance
- Thymi herba + Salviae folium + Menthae piperitae folium
- Manufacturer
- Zakłady Farmaceutyczne POLPHARMA S.A.
- Country
- Poland (PL)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- URPL (Poland)
- Last checked
- September 27, 2026
Packs & prices · 2
- gtin05909990215812
- gtin05909990215829
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of URPL (Poland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/2d90e39b-aaa7-49ef-a0d8-263520d13af5 GET /v1/drugs/2d90e39b-aaa7-49ef-a0d8-263520d13af5?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Zioła do zaparzania w saszetkach",
"source": "urpl",
"strength": "(1000 mg + 500 mg + 500 mg)/sasz.",
"packaging": "05909990215812 ¦ OTC ¦ 14510\n20 sasz. 2 g\n05909990215829 ¦ OTC ¦ 45971\n40 sasz. 2 g",
"substance": "Thymi herba 50 g/100 g + Salviae folium 25 g/100 g + Menthae piperitae folium 25 g/100 g",
"common_name": "Thymi herba + Salviae folium + Menthae piperitae folium",
"pl_product_id": "100090046",
"pozwolenie_nr": "02158",
"auth_procedure": "NAR",
"authorisation_validity": "Bezterminowe"
}See everything about thymi herba + salviae folium + menthae piperitae folium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.